Intent Of La Compana Spanish Ad Lost In Translation
This article was originally published in The Tan Sheet
Executive Summary
Genomma Lab USA featured unsupported claims in an ad comparing its La Pomada de la Compana with competing antibiotic ointments, NAD says. While the firm says it did not intend to make a superiority claim, NAD points out a firm is responsible for advertising “messages it did not intend to convey.”
You may also be interested in...
Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking
The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.
AI Advancing Quickly, But Same FTC, IP Rules Apply – Attorney
Artificial intelligence opportunities are on the rise for marketers, including in the beauty and personal-care sectors. Reed Smith partner Stacy Marcus offers advice on staying compliant with US consumer protection and copyright laws in this rapidly changing world.
Celebrity Beauty Revenues Soar 58% In 2023, With Rihanna Reigning Again
Fenty Beauty by Rihanna was again the leading celebrity beauty brand in 2023, generating sales of $602.4m globally, followed by the hair-care line of Priyanka Chopra Jonas and cosmetics by Kylie Jenner.